11 các kết quả
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to prevention and treatment of atherosclerosis, myocardial infarction and related conditions such as peripheral vascular disease and ischemic stroke, and specifically to drugs that increase levels of HDL.
2.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a useful lipid metabolism improving composition. More particularly, the invention relates to a useful lipid metabolism improving composition comprising S-(.alpha., .beta.-dicarboxyethyl)glutathione, which is a
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a useful lipid metabolism improving medicinal composition. More particularly, this invention relates to a useful lipid metabolism improving medicinal composition containing an ascorbyl tocopheryl phosphate compound or a
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to compounds having inhibitory activity against the biosynthesis of triglycerides and inhibitory activity against the secretion of lipoprotein containing apolipoprotein B, and prophylactic or therapeutic agents for
FIELD OF THE INVENTION
This invention relates to compounds that inhibit the secretion of apolipoprotein B, and to methods of treating and/or preventing atherosclerosis, obesity, diabetes, hyperlipidemia, hyperlipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia,
FIELD OF THE INVENTION
This invention relates to compounds that inhibit the secretion of apolipoprotein B, and to methods of treating and/or preventing atherosclerosis, obesity, diabetes, hyperlipidemia, hyperlipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia,
RELATED APPLICATION
This application claims priority to U.S. Provisional Application No. 61/669,763, filed Jul. 10, 2012, the contents of which are incorporated herein by reference in its entirety.
BACKGROUND OF THE INVENTION
Diabetes mellitus has become pandemic and according to a forecast by the
BACKGROUND OF THE INVENTION
Diabetes mellitus has become pandemic and according to a forecast by the World Health Organization, there will be a sharp increase in the number of diabetic patients by the year 2030. This is an ominous forecast, because managing the long-term complications of diabetes,
BACKGROUND OF THE INVENTION
Diabetes mellitus has become pandemic and according to a forecast by the World Health Organization, there will be a sharp increase in the number of diabetic patients by the year 2030. This is an ominous forecast, because managing the long-term complications of diabetes,
FIELD OF THE INVENTION
The present invention relates to protection against renal failure progression in chronic kidney diseases. This includes the treatment of kidney diseases associated with nephrectomy, renal fibrosis, glomerular sclerosis, and end-stage renal disease. This also includes
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to compounds having inhibitory activity against the biosynthesis of triglycerides and inhibitory activity against the secretion of lipoprotein containing apolipoprotein B, and prophylactic or therapeutic agents for